Objective: To provide up-to-date population-based data on nationwide trends in pneumonia hospitalization rates and associated 30-day mortality. Methods: Using medical databases we identified all in-hospital episodes of pneumonia between 1997 and 2011. We computed age-and sex-standardized hospitalization rates of total and firsttime pneumonia-related hospitalization and adjusted 30-day mortality rates by calendar year. Results: Among 552,528 pneumonia-related hospitalizations in Denmark between 1997 and 2011, 385,985 (69.9%) were first-time events. Total pneumonia hospitalizations increased by 63%, from 4.96 per 1000 population in 1997 to 8.09 in 2011. Rates of first-time pneumonia per 1000 population increased by 33%, from 3.99 in 1997 to 5.31 in 2011. Pneumonia rates stabilized in the mid-00s but primary pneumonia rates increased 16% from 2008 to 2011, most notably among children and young adults. In patients aged !80 years the rate of hospitalizations with secondary pneumonia more than doubled during the study period. Average 30-day mortality remained stable at 13%, but increased slightly over time in patients aged !80 years. Conclusions: In an era of smoking cessation and vaccination efforts, pneumonia hospitalization rates are continuously increasing, largely driven by secondary diagnoses and recurrent pneumonia episodes in elderly patients. Thirty-day mortality remains persistently high. ª
Introduction
Pneumonia remains a leading cause of hospitalization and mortality worldwide [1] . Between the late 1980s and the mid-2000s, pneumonia-associated hospitalizations increased by 20e50% in the United States and Europe, including Denmark [2e6], even after adjusting for population ageing [3e6] . These trends appear paradoxical in light of smoking cessation campaigns and increased uptake of influenza and pneumococcal vaccinations among high-risk groups [7, 8] . Up-to-date European national data are lacking on nationwide trends in pneumonia rates following introduction of the 7-valent pneumococcal conjugate vaccine (PCV-7) in 2007 and other preventive initiatives in Europe during the later 2000s [9, 10] . Moreover, despite recent quality improvement strategies and new treatment guidelines [11] , 30-day mortality remains disturbingly high at 10e15% in population-based studies [4e6] .
The major factor driving increasing pneumonia incidence and persistently high mortality may be a growing prevalence of elderly individuals with chronic diseases necessitating frequent hospitalizations, use of immunosuppressive therapy and surgical interventions [1, 2, 5, 6] . Thus, increasing numbers of recurrent and secondary pneumonia episodes may be a major contributor to the pneumonia burden in Western populations. Existing studies have been hampered by lack of indvidual-level data on comorbidity and history of hospitalizations, including previous diagnoses of pneumonia, or by selective inclusion of hospitals, health insurance systems or age groups [12] .
We therefore conducted a 15-year nationwide, population-based cohort study to examine trends in overall and first-time pneumonia hospitalization rates by type of discharge diagnosis, 30-day mortality, and prognostic impact of age and comorbidity.
Methods Setting
We conducted this cohort study in the entire Danish population of 6,850,096 people from 1997 through 2011. The Danish National Health Service provides universal taxsupported health care, guaranteeing unfettered access to general practitioners and hospitals and partial reimbursement for prescribed drugs. Except for emergencies and severe acute disease, patients' initial contact with the healthcare system is through their general practitioner, who acts as gate-keeper and provides referrals to hospitals and specialists as necessary. Accurate and unambiguous linkage of all registries at the individual level is possible in Denmark by means of the unique personal registry number assigned to all Danish citizens.
Identification of patients with pneumonia
The Danish National Registry of Patients (DNRP) contains information on all inpatient hospitalizations at Danish nonpsychiatric hospitals since 1977 and on all emergency room and hospital outpatient specialist clinic visits since 1995 [13] . Each hospital visit is recorded by physicians with one primary diagnosis and one or more secondary diagnoses classified according to the International Classification of Diseases, 8th edition (ICD-8) until the end of 1993, and ICD-10 thereafter. We used the DNRP to identify all inpatients with a primary or secondary hospital discharge diagnosis of pneumonia [ICD-10 codes J12-J18 (pneumonia), A709 (ornithosis), or A481 (legionellosis)] recorded between 1997 and 2011. We classified patients with pneumonia listed as their primary discharge diagnosis as having primary pneumonia, while those with pneumonia listed as a secondary diagnosis were classified as having pneumonia secondary to another major condition. Patients who had been hospitalized with or without surgery within 30 days prior to the date of index admission were classified as having secondary pneumonia regardless of whether they had a primary diagnosis of pneumonia during the index admission.
Comorbidity data
We computed Charlson Comorbidity Index (CCI) scores for each patient based on DNRP in-patient hospitalization records within 10 years preceding the date of pneumonia diagnosis [14] . We categorized severity of comorbidities as none (CCI score Z 0), medium (CCI score Z 1e2), or high (CCI score !3).
Statistical analysis Hospitalization rates
We computed overall pneumonia hospitalization rates as the total number of pneumonia-related hospitalization episodes per year divided by the corresponding mid-year population (obtained from Statistics Denmark), standardized to the national age and sex distribution in 1997. We then computed rates of first-time incident pneumonia, defined as pneumonia in a patient with no prior pneumonia diagnosis recorded in the DNRP within the preceding 10 years. We stratified rates according to primary pneumonia and secondary pneumonia and by age group (<5, 5e20, 21e40, 41e64, 65e79, and !80 years). Secondary pneumonia were further stratified by the associated primary discharge diagnosis: cardiovascular disease; chronic lung disease; cancer; injuries; admission for medical examination, observation, or rehabilitation; primary septicaemia, meningitis, other respiratory tract infection, unspecified bacterial infection, respiratory failure, or other respiratory tract symptoms; and other primary diagnosis codes.
Because secular changes in rates of pneumonia as a secondary diagnosis may stem from temporal changes in coding practices, we conducted two sensitivity analyses. The first addressed whether there was a trend towards coding more severe cases of pneumonia with alternative primary diagnoses. To examine this we categorized patients with a primary diagnosis of sepsis or respiratory failure combined with a secondary pneumonia diagnosis as having primary pneumonia. In another sensitivity analysis, we categorized all secondary pneumonia patients with primary diagnoses of septicaemia, meningitis, other respiratory tract infection, unspecified bacterial infection, respiratory failure, or other respiratory tract symptoms as having primary pneumonia. Finally, to compare pneumonia rates with overall hospitalization trends, we examined age-and sexstandardized rates of all-cause hospitalizations in Denmark from 1997 through 2011.
Mortality
For patients with a first-time pneumonia-related hospitalization, we ascertained all-cause mortality from the Danish Civil Registration System. Follow-up time was computed from the date of the index hospital admission to the date of death, emigration, or 30 days following the admission date, whichever came first. We constructed KaplaneMeier survival curves to examine crude survival by study period. In addition, we compared mortality over time using Cox regression analysis. The 1997e2001 period was used as reference to estimate 30-day mortality rate ratios (MRRs), adjusting for sex, age group, and comorbidity. All analyses were stratified by age, sex, and comorbidity. We also conducted analyses restricted to patients with primary pneumonia and analyses restricted to patients with secondary pneumonia. The proportional hazards assumption was verified graphically. The Danish Data Protection Agency approved the study.
Results
We identified 552,528 pneumonia-related hospitalizations in Denmark from 1997 through 2011. Of these, 385,985 (69.9%) were first-time hospitalizations. Of patients with a first-time pneumonia hospitalization, 59% had primary pneumonia. Median length of hospital stay for patients with first-time pneumonia increased from 10 days (interquartile range (IQR): 4e52) in 1997e2001 to 13 days (IQR: 4e136) in 2007e2011. For those with primary pneumonia, the median length of stay remained stable at 8.0 days, while for those with secondary pneumonia it increased from 18 days (IQR: 6e110) in 1997e2001 to 28 days (IQR: 7e211) in 2007e2011.
During the study period, the overall number of hospital beds in Denmark declined from 4.64 per 1000 population in 1997 to 2.94 in 2011 and the number of beds in medical wards from 1.94 to 1.21 per 1000 population. Concurrently, the annual number of hospital bed-days declined from 3.16 per 1000 population in 1997 to 2.10 in 2011 while the annual rate of all-cause hospitalization in Denmark increased by 13%, from 202 per 1000 population in 1997 to 228 in 2011.
Characteristics of patients with a first-time hospitalization for pneumonia
The proportions of patients with a first-time secondary pneumonia and patients who had a recent hospitalization or surgical procedure increased during the study period ( Table 1 ). The proportion of pneumonia patients with comorbidity increased from 42.9% in 1997e2001 to 46.2% in 2007e2011, with increases particularly for cancer (from 7.7% to 10.7%), cerebrovascular disease (from 9.6% to 11.5%), and diabetes (from 7.4% to 10.8%). In contrast, there was a slight decrease in patients with chronic pulmonary disease (from 13.8% in 1997e2001 to 12.6% in 2007e2011) and chronic heart failure (from 8.0% in 1997e2001 to 7.1% in 2007e2011) ( Table 1) .
Trends in hospitalization rates
Total pneumonia episodes Fig. 1 shows annual rates of all pneumonia-related hospitalizations and first-time hospitalizations for pneumonia. The age-and sex-standardized annual rate of total pneumonia-related hospitalizations increased by 63%, from 4.96 hospitalizations per 1000 population in 1997 to 8.09 in 2011. Rates of hospitalizations with primary pneumonia increased by 44%, from 3.09 hospitalizations per 1000 population in 1997 to 4.46 in 2011 ( Fig. 2A , supplementary Table 1 ). Over the same period, rates of hospitalizations with secondary pneumonia increased by 95% (from 1.86 to 6.63 per 1000 population). Most of the total pneumonia hospitalization increase up to 2005 was attributable to an 82% increase in hospitalizations with secondary pneumonia. Thereafter, rates of secondary pneumonia remained stable, while rates of hospitalizations with primary pneumonia increased by a further 15%. Age-stratified analyses revealed stable rates of pneumonia among patients <40 years whereas rates increased by 51% among patients aged 65e79 years and by 91% among those aged !80 years. In children <5 years, rates per 1000 fell from 12.00 in 2007 (the year of PCV-7 introduction) to 10.77 in 2009, but then increased again to 14.09 in 2011 (supplementary Table 2 ).
When we stratified hospitalizations with secondary pneumonia by type of primary diagnosis, we observed an 1.7-fold increase in pneumonia coded secondary to septicaemia, meningitis, other infections, and other respiratory tract symptoms, with the rate increasing from 0.68 to 1.86 per 1000 population (Fig. 3) . When we re-categorized patients with a primary diagnosis of sepsis or respiratory tract infections as having primary pneumonia in the first sensitivity analysis, the increase in secondary pneumonia decreased from 95% to 80% over time. When we further recategorized all patients with primary diagnoses of septicaemia, meningitis, unspecified bacterial infection, other respiratory tract infections, respiratory failure, or other respiratory tract symptoms as having primary pneumonia in the second sensitivity analysis, the overall increase in secondary pneumonia fell to 50%. Table 1 ). Thus, the rate increases up to 2005 were mainly due to increasing rates of secondary pneumonia. This increase primarily occurred among patients aged !80 years (supplementary Table 2 ). In comparison, hospitalization rates remained relatively stable over time among those below age 80 years.
Trends in mortality
Overall 30-day mortality in patients with a first-time pneumonia-related hospitalization remained fairly stable at 12.4% among patients diagnosed in 1997e2001, 13.1% in 2002e2006, and 13.1% in 2007e2011 (Table 2 ). After controlling for changes over time in patient age, sex and comorbidity, the adjusted 30-day MRR was 0.99 (95% CI: 0.97e1.02) for patients diagnosed in 2002e2006, and 0.99 (95% CI: 0.97e1.01) for patients diagnosed in 2007e2011, compared to 1997e2001. Stratification by age showed a reduction in relative mortality for patients aged 5e40 years but the estimates were imprecise, while mortality remained virtually unchanged in patients above 40 years (Table 2) . Comorbidity-stratified analyses revealed little change in mortality over time. For patients with primary pneumonia 30-day mortality improved over time except for patients !80 years and those with high level of comorbidity for whom mortality remained unchanged (supplementary Table 3 ). For secondary pneumonia, mortality remained persistently high in most age groups.
Discussion
This study shows a large and increasing burden of pneumonia-related hospitalizations. We found a 63% increase in all hospitalizations with pneumonia between 1997 and 2011, including a large increase in secondary pneumonia in the elderly. The increase in rates of first-time pneumonia was less pronounced with stabilization in the mid-00s, followed by a small increase during the last 3 years of the study, particularly among children and young adults. There was little change in average 30-day mortality over time.
The magnitude of the increase in rates of pneumoniarelated hospitalizations from 1996 through 2005 is consistent with previous European studies [3e5]. The levellingoff in the mid-2000s may compare to Ruhnke et al.'s findings in the US a few years earlier [6] . In their cohort study of 2.7 million patients aged !65 years with communityacquired pneumonia, hospitalization rates increased steadily starting in 1987, with a peak in 1999, and then began to decline, except among persons aged !85 years [6] . In another study, pneumonia-related hospitalization rates decreased by 26% in adults aged 18e39 years and by 15% in adults aged !65 years after 2002 when PCV7 was introduced in the US [15] . Recently, Griffin et al. [16] showed that this decline in the US was sustained during the decade after PCV-7 introduction, most markedly among children but also among adults. A third US study reported a 14.7% reduction in the age-standardized hospitalization rate for lower respiratory tract infections between 1998 and 2006 [17] . In these studies, rates of total versus firsttime pneumonia episodes were not assessed. In contrast to the declining rates of pneumonia-related hospitalization in the US, we observed a more substantial and continuous increase in rates of total pneumonia and in particular in secondary diagnoses of pneumonia in the elderly. Increasingly frequent hospitalizations for reasons other than pneumonia may have led to more cases of subsequent pneumonia. Possible factors also include improved survival of patients with underlying chronic conditions and more frequent and aggressive immunosuppressive treatments that make patients vulnerable to pneumonia. These factors may also explain the increase in recurrent pneumonias. Still, the rate of all-cause hospitalizations in Denmark increased much less than pneumonia-related hospitalizations over the study period. The increase in hospitalizations for pulmonary infections or respiratory tract symptoms accompanied by a secondary diagnosis of pneumonia suggests that changes in coding and documentation contributed to the rise in secondary diagnoses of pneumonia [12] . This may particularly be the case after the introduction of the diagnosis related group system as a prospective payment system around year 2000. The stabilization in rates of first-time hospitalizations with primary pneumonia from 2005 through 2008 parallels the reduction in invasive pneumococcal disease the year after the introduction of PCV7 in the childhood vaccination program in Denmark [9, 18] . The subsequent increase, particularly in the youngest age groups during 2009e2011, may relate to emergence of pH1N1 influenza in early 2009 [19, 20] and to the epidemic of Mycoplasma pneumonia infection in Denmark during the autumn and early winter in both 2010 and 2011 [21] . The general plateau in rates of first-time pneumonia starting in 2005 preceded both the 2007 introduction of PCV7 and a public smoking ban enacted in August 2007. However, smoking had decreased in Denmark long before [22] , and in 2002 the Danish Ministry for the Interior and Health issued an executive order of free influenza vaccination for all people aged !65 years [23] . In the subsequent years this was extended to include other high-risk groups. From 2002 through 2010 the annual influenza vaccination uptake among people !65 years in Denmark has been between 47 and 55% with a slightly increasing trend over time [24] .
It is a concern that the crude 30-day mortality remained practically unchanged between 1997 and 2011. More than half of pneumonia patients had important preexisting comorbidities, and 30-day mortality increased sharply with comorbidity level. Recent population surveillance data show that prevalence of diabetes and cancer increased in Denmark during the 2000s, while prevalence of cardiovascular disease and COPD levelled off [25] , consistent with our findings among pneumonia patients. We saw a decline in comorbidity-adjusted mortality over time only in the youngest adults, and those aged 65e79 years. In contrast, we found that the very elderly experienced increasing pneumonia incidence without mortality reductions e somewhat in disagreement with previous cohort studies [2e6,16] . There is a paucity of studies examining time Figure 3 Age-and sex-standardized rates per 1000 population for total hospitalizations with secondary pneumonia, stratified by primary discharge diagnoses.
trends in pneumonia prognosis according to level of comorbidity among patients. Our data thus extend previous research. Advanced age and comorbidity may influence pneumonia prognosis in several ways. Less clear-cut presenting symptoms in the elderly may lead to delays in diagnosis and therapy [26e28] . Incident pneumonia may negatively interact with underlying chronic medical illnesses, such as chronic obstructive pulmonary disease and chronic heart disease. In addition, immune dysfunction is common in the elderly, either as a consequence of comorbid illness or directly due to ageing [29] . Finally, quality or intensity of pneumonia care and treatment may be associated with age and debilitating comorbidity. In a study of 36,516 patients with community-acquired pneumonia in Alberta, Canada, Carriere et al. [30] observed that despite an increasing length of stay with higher age, use of specialized medical care and hospital costs decreased with age.
Our pneumonia-related hospitalization rates and mortality estimates are based on a nationwide cohort study conducted in a setting where a national health service provides unfettered access to health care, thus largely avoiding referral and diagnostic biases. Nonetheless, several issues should be considered in interpreting our results. Some pneumonia coding errors may have occurred. The predictive value of a hospital diagnosis of pneumonia in Denmark is high, i.e., 90% [5] , similar to other settings, but might be lower for secondary episodes. We conducted sensitivity analyses to address concerns about validity of secondary episodes and changes in coding over time. These analyses showed that the rising trend for secondary pneumonia was robust to even major changes in coding practice. Our study was restricted to inpatients, and up to 80% of pneumonia episodes are treated in primary care [31] . Increasing hospitalization rates may be explained partly by general practitioners lowering their threshold over time for admitting patients with mild pneumonia or hospitalizing a higher proportion of frail or terminal patients who previously may have been treated at home. Still, the median length of stay and the 30-day mortality rate was virtually constant over the study period, which probably would not have occurred if the average severity of hospitalized cases had changed substantially. The higher mortality reduction over time for primary versus secondary pneumonia may suggest that increasing pneumonia rates could be related to more comprehensive coding of secondary diagnoses.
In conclusion, this study shows a large increase over time in pneumonia-related hospitalizations in Denmark. Pneumonia will continue to have a substantial impact on health care needs. The short-term prognosis remains virtually unchanged and unequal improvements in prognosis suggest that more data are needed on the effectiveness of interventions to reduce mortality among both the very elderly and patients with co-existing chronic diseases.
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